Aldesleukin

Proleukin 18 X 10(6) Ui Polvo Para Solucion Inyectable O Para Perfusion

18 MILLONES UI polvo para solución inyectable y para perfusiónSpainMarketedAuthorised 24 Jan 2000

In other countries

The same active substances on other registers, the same brand first.

ProleukinBrazil · Adium S.A.Same brand
ProleukinCanada · 22000000 UNIT / VIAL · Powder For Solution · Iovance Biotherapeutics Manufacturing LLCSame brand
ProleukinItaly · Polvere per soluzione iniettabile/per infusione · Iovance Biotherapeutics BVSame brand
Proleukin 18 x 1.000.000 IE poeder voor oplossing voor injectie of infusieNetherlands · Poeder voor oplossing voor injectie of infusie · Iovance Biotherapeutics B.V.Same brand
ProleukinUnited States · 22MIU/VIAL · vial · ChironSame brand
Guna-Il 2United StatesSame substance

Packs

Pack	Code	Status
PROLEUKIN 18 X 10(6) UI POLVO PARA SOLUCION INYECTABLE O PARA PERFUSION , 10 viales

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Aldesleukin

Proleukin 18 X 10(6) Ui Polvo Para Solucion Inyectable O Para Perfusion

18 MILLONES UI polvo para solución inyectable y para perfusiónSpainMarketedAuthorised 24 Jan 2000

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
PROLEUKIN 18 X 10(6) UI POLVO PARA SOLUCION INYECTABLE O PARA PERFUSION , 10 viales

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Aldesleukin
Strength: 18 MILLONES UI
Dosage form: polvo para solución inyectable y para perfusión
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 24 Jan 2000
Registration: 62287
Marketing authorisation holder: Iovance Biotherapeutics B.V.
Procedure: National, MRP or DCP
Supply: Uso Hospitalario